Literature DB >> 3578650

Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis.

J K Frenkel, A Escajadillo.   

Abstract

Seemingly intact cysts and sequential stages of disintegrating cysts of Toxoplasma were identified immunohistologically within developing microglial nodules in a Panamanian night monkey (Aotus lemurinus). This monkey had been successfully immunized and challenged 5 months earlier. This supports the hypothesis that glial nodules unassociated with Toxoplasma tachyzoites may represent the tombstone of a Toxoplasma cyst. Disintegration of cysts may give rise to clinical encephalitis in the presence of apparently adequate immunity.

Entities:  

Mesh:

Year:  1987        PMID: 3578650     DOI: 10.4269/ajtmh.1987.36.517

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  41 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Molecular cloning and characterization of an SRCAP chromatin remodeling homologue in Toxoplasma gondii.

Authors:  William J Sullivan; M Alexandra Monroy; Wolfgang Bohne; Karuna C Nallani; John Chrivia; Peter Yaciuk; Charles K Smith; Sherry F Queener
Journal:  Parasitol Res       Date:  2003-01-28       Impact factor: 2.289

3.  In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii.

Authors:  F G Araujo; J Huskinson-Mark; W E Gutteridge; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures.

Authors:  D S Lindsay; B L Blagburn; J E Hall; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Bradyzoite development in Toxoplasma gondii and the hsp70 stress response.

Authors:  L M Weiss; Y F Ma; P M Takvorian; H B Tanowitz; M Wittner
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 6.  Toxoplasma gondii and ocular toxoplasmosis: pathogenesis.

Authors:  C E Pavesio; S Lightman
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

Review 7.  Toxoplasma Effectors Targeting Host Signaling and Transcription.

Authors:  Mohamed-Ali Hakimi; Philipp Olias; L David Sibley
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

8.  Targeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice.

Authors:  C Mercier; D K Howe; D Mordue; M Lingnau; L D Sibley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  A morphological study of chronic cerebral toxoplasmosis in mice: comparison of four different strains of Toxoplasma gondii.

Authors:  D J Ferguson; J Huskinson-Mark; F G Araujo; J S Remington
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

10.  Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.

Authors:  Valentina Martin; Alicia Supanitsky; Pablo C Echeverria; Silvana Litwin; Tamara Tanos; Adolfo R De Roodt; Eduardo A Guarnera; Sergio O Angel
Journal:  Clin Diagn Lab Immunol       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.